Chemfab Alkalis Q1 FY27 Results: Profit Before Tax ₹130 Crore, Appoints New Auditors
Chemfab Alkalis reported Q1 FY27 results with standalone Profit Before Tax at ₹130.24 Lakhs and consolidated Profit Before Tax at ₹222.37 Lakhs. The company also approved the appointment of M S K A & Associates LLP as Statutory Auditors for five years, pending shareholder approval at the AGM.
The financial results indicate a decline in profitability compared to the same quarter last year, which could impact investor sentiment. The appointment of new auditors is a standard corporate governance event but may lead to a period of adjustment.
The results show a mixed performance with a decrease in profit before tax compared to the previous year's quarter, but the appointment of new auditors is a routine corporate action. No significant positive or negative triggers are evident.
Chemfab Alkalis Limited announced its un-audited standalone and consolidated financial results for the quarter ended June 30, 2026. The company's Board of Directors, in a meeting held on July 29, 2026, approved these results. For the quarter, the standalone Profit Before Tax stood at ₹130.24 Lakhs, while consolidated Profit Before Tax was ₹222.37 Lakhs.
The Board also approved the appointment of M/s. M S K A & Associates LLP as the Statutory Auditors for a first term of five consecutive years, subject to shareholder approval at the upcoming Annual General Meeting (AGM). The meeting commenced at 12:00 PM and concluded at 6:00 PM on July 29, 2026.
What to do with a filing like this
Chemfab Alkalis Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Chemfab Alkalis Limited. Read the original for the full detail.